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Abstract: This study investigated the effect of transplantation of bone marrow mesenchymal stem cells (BM-MSCs) on functional
deterioration and neuroinflammatory response in aged C57BL/6J mice. Mice were divided into 3 groups: normal aged group, saline
control group, and BM-MSCs treatment group. Saline and BM-MSCs were administrated by intraventricular injection into the right
ventricle. Spatial Y-maze (SYM) test, novel objective recognition (NOR) test, and locomotor activity test were used to evaluate cognitive
and locomotor ability at 7 and 42 days after transplantation. Microglia and astrocyte expression in the hippocampus CA1 region
and dentate gyrus (DG) were evaluated by immunohistochemical method. Furthermore, the content of TNF-α, IL-1α, and IL-1β in
the hippocampus and cortex were detected with ELISA. We found that BM-MSCs transplantation increased time in novel arm and
percentage of alteration in SYM test, discrimination ratio and discrimination index in the NOR test, and traveled total distance and
mean velocity in the locomotor activity test. It also inhibited microglia and astrocyte expression, and reduced the content of IL-1α
and IL-1β in the hippocampus. Our results suggested that BM-MSCs transplantation could delay cognitive and locomotor function
deterioration through inhibiting neuroinflammation response, which would provide a rationale for exploring the viability of using BMMSCs transplantation in cognitive deficit diseases.
Key words: Bone marrow mesenchymal stem cells transplantation, inflammatory response, aged mice, microglia, functional deterioration

1. Introduction
To prevent and improve age-related brain dysfunction
has become an important and emergent issue with the
rise in life expectancy. Actually, cognitive and locomotor
function deficit are hallmarks not only of pathological
aging but also of healthy aging processes, which may be
due to neuroinflammation in the hippocampus (Boehme
et al., 2014; Babcock et al., 2015), reduced synaptic
plasticity and neurogenesis (Cutuli et al., 2014; Gebara
et al., 2015), etc. Neuroinflammation, including increase
in proinflammatory cytokines, as well as microglia and
astrocyte activation, has been reported to contribute to
the cognitive and behavioral impairment induced by
radiation, Alzheimer disease, Parkinson disease, etc.
(Jenrow et al., 2013; Kim et al., 2015; Park et al., 2015). Thus,
manipulations aimed at inhibiting neuroinflammation
response represent a promising approach for alleviating
age-related cognitive impairment as well as behavioral
deterioration.
Bone marrow mesenchymal stem cells (BMMSCs), multipotent progenitor cells with self-renewal
* Correspondence: lv.gy@263.net

ability and the capacity to differentiate several distinct
mesenchymal lineages, are widely used in several
central nervous system (CNS) diseases, such as cortical
ischemia (Franco et al., 2012), spinal cord injury (Han
et al., 2014), and spinocerebellar ataxia (Chang et
al., 2011). Numerous studies showed that BM-MSCs
transplantation could reduce inflammation, induce
repair of nerve cells, and restore nerve function by
secreting neurotrophic factors and antiinflammatory
cytokines (Zhou et al., 2009; Pastor et al., 2012; Han
et al., 2014), therefore supporting beneficial outcomes
when BM-MSCs were transplanted into a variety of
disease models involving inflammation.
However, these studies did not address whether it
could inhibit neuroinflammation response and delayed
functional deterioration in aged mice. Therefore, in the
present study, we examined the effects of BM-MSCs on the
activation of microglia and astrocyte expression, as well as
on inflammatory mediators in the hippocampus in aged
C57BL/6J mice. The effects of cognitive and locomotor
function deterioration were also investigated.
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2. Materials and methods
2.1. Animals and groups
Male aged C57BL/6J mice (24 months old at the onset of
the study) were used (Shanghai Slyke Laboratory Animal
Limited Corporation, Certificate No. SCXK 2012-0002,
China). The animals were group-housed (3–4 mice/
cage) under a 12:12 h light–dark cycle with controlled
temperature of 22 ± 1 °C and humidity of 50 ± 10%. Food
and water were provided ad libitum. The animals were
divided in 3 groups: (1) normal aged mice treated with
nothing (group name: normal; n = 12); (2) mice treated
with saline 2 µL/mouse (group name: saline; n = 12); (3)
mice treated with BM-MSCs cultures 2 µL/mouse (1 × 108
cells) (group name: BM-MSCs; n = 12). All experiments
were carried out in accordance with the National Institute
of Health Guide for the Care and Use of Laboratory
Animals.
2.2. Experimental procedures
The mice were tested in the following validated behavioral
tasks at 7 and 42 days after intraventricular injection with
saline or BM-MSCs: locomotor activity, novel object
recognition (NOR) test, and spatial Y-maze (SYM) test.
After behavioral tests at 42 days after transplantation,
the animals (8 mice in each group) were transcardially
perfused followed with 10% chloral hydrate (4 g/kg). Then
their brains were removed and cut into 10-µm coronal
sections on a cryomicrotome (CM1900, Leica, Germany)
to perform an immunohistochemistry evaluation. The
hippocampus and cortex of the other mice were separated
to detect content of IL-1α, IL-1β, and TNF-α by ELISA.
2.3. BM-MSCs culture and transplantation
The BM-MSCs line originated from a C57BL/6J mouse
(MUBMX-01001) and culture media were both obtained
from Cyagen Biosciences Company, Guangzhou. The
medium was replaced every other day and the cell line was
passaged once every about 5 days. The mice were anesthetized
intraperitoneally with 10% chloral hydrate (4 g/kg) and placed
into a stereotaxic apparatus (Benchmark 463001, Myneurolab
Company, USA). The right lateral ventricle was targeted at
the following coordinates: from bregma –0.22-mm anterior,
1.0-mm lateral, 2.6-mm depth according to mouse brain
stereotaxic atlas. Next, 2 µL of BM-MSCs (about 1× 108 cells)
or saline was injected at a rate of 0.4 µL/min. After injection,
the syringe was left in place for an additional 5 min and
gradually removed. The surface of the skull was covered with
dental glue and the scalp was sutured and disinfected with
75% ethanol. Finally, the mice were warmed and returned to
their cages after complete reawakening.
2.4. Behavioral tests
2.4.1. SYM test
The Y-maze apparatus (Huaibei ZhengHua Biological
Instrument Equipment Co., Ltd, China) consisted of three
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identical arms with a 120° angle between adjacent arms.
The three arms were designated as follows: start arm and
familiar arm always open, and novel arm blocked during
the first trial and opened during the second trial. The SYM
test apparatus consisted of two trials separated by a 4-h
intertrial interval. During the first trial (training phase),
the mouse was allowed to explore the start and familiar
arms with the novel arm being blocked, and this lasted 10
min. During the second trial (retention phase), the mouse
was allowed to freely explore all three arms, and this lasted
5 min. The trials were recorded and analyzed by a video
analyzer (Ethovision XT, Noldus, Netherlands). Total time
spent in the novel arm and the percentage of alteration in
the retention phase were analyzed. Spontaneous alteration
is considered when a mouse visits a new arm but does
not return to one of the previously visited two arms.
The percentage of alteration = [number of spontaneous
alteration/(number of entries – 2)] × 100 (Wahl et al.,
1992).
2.4.2. NOR test
The NOR test is a nonrewarded, ethologically relevant
paradigm based on the spontaneous exploratory behavior
of rodents that measures recognition memory. It is widely
used in a variety of animal models of human conditions
where cognition is impaired. As described previously
(Kajitani et al., 2010), the task consisted of three trials:
habituation (to minimize the effects of stress), pretest (to
explore two identical objects), and test (to explore one
familiar object and one novel object). During habituation,
mice were introduced in the empty chamber and left
to freely explore it for 10 min. Afterwards, they were
put in their home cages for 5 min, during which two
identical objects (familiar object: cubic crude wood 4
cm in diameter) were placed in two opposite corners of
the chamber. During the pretest, mice were placed in the
center of the chamber oriented toward the objects and
allowed to explore the objects for 5 min. After a 1.5-h
intertrial interval, mice were placed again for 5 min in the
chamber, where one of the familiar objects was replaced by
a novel one (novel object: cylindrical crude wood 4 cm in
diameter and height). The duration time, which the mice
took to explore the familiar and novel object, was recorded.
Each recognition trial was videotaped and scored for time
spent in the zone surrounding each object using Ethovision
software (EthoVision XT; Noldus Information Technology,
Netherlands). Discrimination ratio and discrimination
index were calculated by taking the difference between the
times spent exploring the novel and familiar objects and
this was divided by the time spent exploring both objects
during the pretest and test phase. Discrimination ratio =
[N / (N + F)] × 100%), and discrimination index = [(N – F)
/ (N + F)] × 100%. (N: the time to explore a novel object,
F: the time to explore a familiar object). Exploration was
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2.6. ELISA detection
At 42 days after BM-MSCs transplantation, 4 mice in
each group were decapitated quickly. The hippocampus
and cortex were separated on ice, and then sonicated to
obtain tissue homogenates. After removing particulars
by centrifugation (2000 × g, 4 °C, 20 min), the assay was
immediately performed. Content of IL-1α, IL-1β, and
TNF-α were measured using the respective ELISA kit
(Shanghai Elisa Biotech Co., Ltd, China) according to the
manufacturer’s instructions. Finally, optical density was
determined (absorbance at 450 nm) on a plate reader.
2.7. Statistical analysis
The data are expressed as mean ± standard error (SEM).
Compared with the normal or saline group, the effects of
BM-MSCs transplantation were performed using one-way
ANOVA with Bonferroni post hoc test using SPSS 16.0
for Windows. The data of the NOR test in the test were
compared with those in the pretest using an independent
t-test. P < 0.05 was considered to be statistically significant.
3. Results
3.1. Effects of BM-MSCs transplantation on the SYM test
in aged C57BL/6J mice
Compared with the normal group, treatment with saline
did not change time in the novel arm or percentage
of alteration in the SYM test at 7 and 42 days after
transplantation. Compared to the saline group (Figures
1a and 1b), BM-MSCs transplantation not only increased
time in the novel arm but also percentage of alteration at
7 and 42 days. However, there was no difference between
the BM-MSCs group and the normal group at 7 days after
transplantation (Figure 1a).
3.2. Effects of BM-MSCs transplantation on the NOR test
in aged C57BL/6J mice
At day 7 after transplantation, there was no difference in
the discrimination ratio or discrimination index among

Percentage of alteration (%)

defined when the distance between the mouse’s nose and
the object is ≤ 2 cm when it faces the object.
2.4.3. Locomotor activity test
The locomotor activity test was carried as described
previously (Schmidt et al., 2008) and recorded using a
Spontaneous Activity Video Analysis System (JLBehvLAG-4, Shanghai Jiliang Software Technology Co., Ltd.
China). Each mouse was placed gently in the center of the
chamber (40 × 40 × 35 cm). The locomotor tracks were
continuously recorded by a video camera for 1 h and
analyzed. The following parameters were determined:
(a) total traveled distance (m); (b) mean traveled velocity
(cm/s) within 1 h, which reflected the spontaneous activity
of animals. After each test session, the enclosures were
thoroughly cleaned with 70% ethanol solution.
2.5. Immunohistochemical evaluation
First, 10-µm sections were treated with 0.3% Triton-X 100
for 1 h, then 0.3% H2O2 in methanol for 30 min, hydrated
gradually to distilled water, and incubated for 1 h with 5%
BSA to block nonspecific immune reactions. Afterwards,
sections were incubated overnight at 4 °C with polyclonal
rabbit anti-Iba1 (1:400, Wako Pure Chemical Industries,
Ltd., Japan) and -GFAP antibodies (1:200, Wuhan Boster
Biological Engineering Co., China). The next day, after
washing, the sections were incubated with biotinylated
goat anti-rabbit IgG (1:200, Abcam, USA) for 1 h following
with incubation with avidin–biotin–peroxidase complex
(1:200, Wuhan Boster Biological Engineering Co., China)
for 2 h. Finally, the sections were exposed for 0.5–2 min
to 0.01% 3,3’-diaminobenzidine (Wuhan Boster Biological
Engineering Co., China) followed with hematoxylin
counterstaining for 0.5–1 min. Normal goat serum was
used instead of the primary antibody in the control
sections. The morphological change and the expression
number of microglia and astrocyte in hippocampal CA1
region and dentate gyrus (DG) were observed.

Figure 1. BM-MSCs transplantation increased novel time and percentage of alteration in the SYM test at 7 and 42 days after
transplantation. Measurement of the time in novel arm (a) and percentage of alteration (b). Data are expressed with mean ± SEM.
Compared with normal group, *P < 0.05; Compared with saline group, #P < 0.05.
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all groups in the NOR test (data not shown). However,
at day 42 after transplantation, treatment with saline
still did not change the discrimination ratio (Figure 2a)
or discrimination index (Figure 2b) compared with the
normal group. BM-MSCs transplantation, on the other
hand, increased the discrimination ratio (Figure 2a) and
discrimination index (Figure 2b) in the NOR test when
compared with the normal or saline group. There was no
significant difference in discrimination ratio (Figure 2a)
or discrimination index (Figure 2b) between the test and
pretest in the normal and saline groups. However, BMMSCs treatment increased the discrimination ratio (Figure
2a) and discrimination index (Figure 2b) in the test.
3.3. Effects of BM-MSCs transplantation on the
locomotor activity test in aged C57BL/6J mice
At 7 days after transplantation, in the saline group and BMMSCs group traveled total distance (Figure 3a) and mean
velocity (Figure 3b) within 1 h were not affected in the

locomotor activity test compared with the normal group.
However, at 42 days after transplantation, BM-MSCs
transplantation increased traveled total distance (Figure
3a) and mean velocity (Figure 3b) within 1 h. There was no
difference between the saline group and the normal group
at 42 days after transplantation (Figures 3a and 3b).
3.4. BM-MSCs transplantation inhibited the expression
of microglia in the hippocampus CA1 region and DG
We assessed microglia activation by detection of the
expression of Iba-1 by immunohistochemistry. Iba-1 can
detect both resting and activated microglia, while resting
microglia are activated and transformed from a ramified
to an amoeboid morphology in the aged brain. As shown
in Figure 4a, all groups exhibited activated microglia,
but few were expressed in BM-MSCs-treated mice. The
number of activated microglia in the BM-MSCs group was
decreased compared with the normal and saline groups in
both the hippocampus CA1 region and DG (Figure. 4b).

Pretest
Test

Figure 2. BM-MSCs transplantation increased discrimination ratio and discrimination index in the NOR test at 42 days after transplantation.
Measurement of discrimination rario (a) and discrimination index (b). Data are expressed with mean ± SEM. Compared with normal
group in test, *P < 0.05; Compared with saline group in test, #P < 0.05; Compared with BM-MSCs group in pretest, &&P < 0.01.

Figure 3. BM-MSCs transplantation increased total distance and mean velocity within 1 h in the locomotor activity test at 7 and 42 days
after transplantation. Measurement of traveled total distance (a) and mean velocity (b) within 1 h. Data are expressed with mean ± SEM.
Compared with normal group, *P < 0.05; Compared with saline group, #P < 0.05.
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Figure 4. BM-MSCs transplantation inhibited the expression of microglia in the hippocampus CA1 region and DG in aged C57BL/6J
mice at 42 days after transplantation. Morphological change (a) and expression number change (b) of microglia at 42 days after BMMSCs transplantation in the hippocampus CA1 region and DG. Data are expressed with mean ± SEM. Compared with normal group,
**
P < 0.01; Compared with saline group, ##P < 0.01. Scale bar = 500 µm.

Saline treatment did not change the number of microglia
expressed (Figure 4b).
3.5. BM-MSCs transplantation inhibited the expression
of astrocytes in hippocampus CA1 and DG
GFAP positive cells were expressed in the hippocampus
CA1 region and DG at 42 days after transplantation
in all groups (Figure 5a). Injection with saline had no
effect on astrocyte number (Figure 5b), but BM-MSCs
treatment inhibited the expression of astrocytes in both
the hippocampus CA1 region and DG (Figure 5b).
3.6. BM-MSCs transplantation decreased the expression
of IL-α and IL-β in the hippocampus
Compared with the normal group, the saline group did not
have changed expression of IL-α (Figure 6a), IL-β (Figure

6b), or TNF-α (Figure 6c) in the hippocampus or cortex.
BM-MSCs transplantation decreased IL-α (Figure 6a) and
IL-β (Figure 6b) expression in the hippocampus but not
in the cortex. However, BM-MSCs transplantation had no
effect on TNF-α expression in the hippocampus or cortex
(Figure 6c).
4. Discussion
In this work we have shown that BM-MSCs transplantation
is capable of delaying cognitive and locomotor function
deterioration in aged mice. Moreover, it inhibited the
activation of microglia and astrocytes, followed by a
decrease in proinflammatory factors.
Our research found there was no difference in mortality
among the groups (data not shown). Some papers reported
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Figure 5. BM-MSCs transplantation inhibited the expression of astrocyte in the hippocampus CA1 region and DG in aged C57BL/6J
mice at 42 days after transplantation. Morphological change (a) and expression number change (b) in astrocytes at 42 days after BMMSCs transplantation in the hippocampus CA1 region and DG. Data are expressed with mean ± SEM. Compared with normal group,
*
P < 0.05; Compared with saline group, #P < 0.05. Scale bar = 500 µm.

that BM-MSCs significantly prolonged the graft survival
time of other organs, such as the skin and heart (Hu et al.,
2013; Wu et al., 2013; Zhang et al., 2013), but no reports
showed higher lifetime in vivo. Our results also did not
verify whether it can lengthen lifetime in vivo yet.
BM-MSCs are relatively easy to obtain, require
minimum manipulation, and can be extracted and
rapidly reimplanted into the region of interest with
different medications. At present, it was administrated
by intraventricular, intravenous, and intraperitoneal
injection to treat various CNS diseases (Yamawaki-Ogata
et al., 2014; Zhu et al., 2014). However, compared with
intravenous or intraperitoneal injection, intraventricular
injection can make the cells reach the brain tissue directly,
and avoid the shielding effect of the blood–brain barrier
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and peripheral organs. Thereby the dosage is reduced and
the success rate of transplantation increased (Kopen et al.,
1999).
Another point of this research is the effect of BMMSCs transplantation on microglia and astrocyte
expression in the hippocampal CA1 region and DG. In the
aged brain, microglia is primed to be activated. Moreover,
astrocytes in the aging brain express characteristics of
senescence-associated secretory phenotype (Salminen
et al., 2011; Norden and Godbout, 2013). Microglia are
the primary immunocompetent cells in brain tissue and
microglia-mediated inflammation is associated with
the pathogenesis of various neuronal disorders and a
healthy aging brain, which are major cellular sources
of TNF and IL-1 family of cytokines, including IL-1α

b
IL-β content (mg/mL)

a

IL-α content (mg/mL)

TNF-α content (mg/mL)
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c

Figure 6. BM-MSCs transplantation decreased the content of proinflammatory factors in the hippocampus and cortex at 42 days
after BM-MSCs transplantation. Measurement of IL-1α (a), IL-1β (b), and TNF-α (c) content. Data are expressed with mean ± SEM.
Compared with normal group, *P < 0.05; Compared with saline group, #P < 0.05.

and IL-1β (Boehme et al., 2014; Babcock et al., 2015).
Several studies suggest that overactivated microglia is a
detrimental factor in CNS diseases (Hamby et al., 2007),
but other experimental evidence showed inhibiting
overactivated microglia exerted a protective effect in CNS
diseases (Neumann et al., 2008). Furthermore, astrocyte
activation, associated with the release of proinflammatory
factors IL-1β, IL-6, and TNF-α, is also a hallmark of
multiple brain diseases (Kong et al., 2015). According
to Boehme et al. (2014), astrocytic marker-GFAP and
microglial marker-Iba1 significantly increased in the
aged hippocampus. Therefore, our study was conducted
for immunohistochemical analysis of the microglia
marker Iba1, astrocyte marker GFAP, and quantification
of inflammatory markers in the hippocampus to evaluate
the effect of BM-MSCs transplantation on aged mice.
The results showed BM-MSCs transplantation inhibited
microglia and astrocyte activation, leading to reduced
production of proinflammatory factors, including IL-1α
and IL-1β, but without change in TNF-α, which was in
accordance with the antiinflammatory properties of BMMSCs transplantation in other CNS diseases (Han et al.,
2014; Liu et al., 2014). Increased IL-1α and IL-1β have been
described in many studies assessing the aged brain (Griffin
et al., 2006; Henry et al., 2009). TNF-α is released during
the earliest stages of CNS injury (Ersahin et al., 2012).
Therefore, contradictory results have also been found for

TNF-α in age-related diseases (Lanzrein et al., 1998; Griffin
et al., 2006), which may be related to the dysregulation of
proinflammatory factors in the aged brain. In addition,
our results found BM-MSCs transplantation had no effect
on proinflammatory factors in the cortex. The cortex is
a complex structure in the brain that includes frontal,
temporal, parietal, occipital, and insular lobes. Each region
has different effects on proinflammatory factors. In the
future, to subdivide the cortex and detect the change in
proinflammatory factors are essential.
Furthermore, in our study, mice were tested in the
following validated behavioral tasks tapping distinct
hippocampal-dependent abilities: SYM test to assess
spatial memory and NOR test to analyze novelty
recognition memory, which are often used to assess
learning and memory ability in CNS diseases (Rachmany
et al., 2013; Huang et al., 2014). Locomotor activity
test in an open field is frequently used to evaluate basic
behaviors used in psychological and pharmacological
investigations (usually in rodents) (Zhang et al., 2006).
Aging was accompanied by a decline in learning and
memory ability, which demonstrated in our results no
difference between the test and pretest in the NOR test.
However, in fact, discrimination ratio and discrimination
index in the test increased in adult mice compared with
the pretest (Kajitani et al., 2010; Saleem et al., 2014). BMMSCs transplantation delayed cognitive deterioration,
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which manifested as increased time in the novel arm and
percentage of alteration in the SYM test, and increased
discrimination ratio and discrimination index in the NOR
test. Furthermore, BM-MSCs treatment increased the
traveled distance and velocity in the locomotor activity
test, which indicated locomotor function improvement.
The cognitive and locomotor function improvement may
be related to decreased inflammatory responses in the
hippocampus.
Based on these results, intraventricular injection with
BM-MSCs can inhibit the overactivation of microglia and
astrocytes, followed by a reduction in proinflammatory
factors in the hippocampus in aged C57BL/6J mice. As

a result, it delayed cognitive and locomotor function
deterioration. Therefore, BM-MSCs transplantation could
provide a rationale for exploring the viability of using BMMSCs transplantation in cognitive deficit diseases.
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